GLP-1受体激动剂类药物在肥胖治疗中的研究现状

打开文本图片集

【中图分类号】R965.3 【文献标志码】A

【AbstractAsachronicandcomplexdisease，obesitycancause manyotherdiseases.Obesityisinfluencedbymanyfactors.Atresent， themaintreatmenttodsfobsityareavioralinterentiodicatiodocopictrapyndseeegstrectoy.a throughsandprogresshaveachievedinmedication.Thisarticlemailyintroducesthelatestclinicalsituationandadversereactiosof severalrepresetativedugsiucago-likepptide-eptorgostsuchsliagutidmglutideniepaide.e mainlyaims toanalyzethesafetyandeficacyoftheseanti-obesitydrugsandprovideguidanceforfutureclinicalmedication.

【Key words】glucagon-like peptide-1 receptor agonists;type 2 diabetes;obesity;body weight

肥胖是一种慢性复杂疾病，会引起很多相关疾病如呼吸睡眠暂停综合征、动脉粥样硬化性心血管疾病、多囊卵巢综合征等。（剩余13959字）